Introduction to systematic reviews and meta-analysis

Respirology

Volumn 21, Issue 4, 2016, Pages 626-637

  McKenzie, Joanne E ^a   Beller, Elaine M ^b   Forbes, Andrew B ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b BOND UNIVERSITY   (Australia)

^c Victorian Centre for Biostatistics (ViCBiostat)   (Australia)

Author keywords

fixed effect model; meta analysis; random effects model; systematic review; tutorial

Indexed keywords

CORTICOSTEROID; PLACEBO;

ASTHMA; DATA ANALYSIS SOFTWARE; DATA SYNTHESIS; EARLY INTERVENTION; EFFECT SIZE; EMERGENCY WARD; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MEDICAL RESEARCH; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; VALIDITY; VARIANCE; BIOLOGY; CLINICAL DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; HOSPITAL EMERGENCY SERVICE; LITERATURE; PROCEDURES; PULMONOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TRENDS;

ADRENAL CORTEX HORMONES; ASTHMA; COMPUTATIONAL BIOLOGY; DECISION SUPPORT SYSTEMS, CLINICAL; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; META-ANALYSIS AS TOPIC; PULMONARY MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; TREATMENT OUTCOME;

EID: 84964577758     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12783     Document Type: Review

References (68)

1. Bastian H, Glasziou P, Chalmers I,. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med. 2010; 7: e1000326.
2. Mulrow CD,. The medical review article: state of the science. Ann. Intern. Med. 1987; 106: 485-8.
3. Teagarden JR,. Meta-analysis: whither narrative review? Pharmacotherapy 1989; 9: 274-81; discussion 81-4.
4. Thompson SG,. Meta-analysis of clinical trials. In:, Armitage P, Colton T, (eds) Encyclopedia of biostatistics, 2nd edn. John Wiley & Sons, Hoboken, N.J., 2005.
5. Last JM, International EA,. A dictionary of epidemiology. Oxford University Press, New York, 2001.
6. Leeflang M, Deeks J, Takwoingi Y, Macaskill P,. Cochrane diagnostic test accuracy reviews. Syst. Rev. 2013; 2: 82.
7. Higgins JPT, Green SE,. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Accessed 2 Apr 2015]. Available from URL: www.cochrane-handbook.org.
8. Group CPM. 2015. [Accessed 2 Apr 2015]. Available from URL: https://prognosismethods.cochrane.org/scope-our-work.
9. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG,. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007; 4: e78.
10. Turner L, Galipeau J, Garritty C, Manheimer E, Wieland LS, Yazdi F, Moher D,. An evaluation of epidemiological and reporting characteristics of complementary and alternative medicine (CAM) systematic reviews (SRs). PLoS One 2013; 8: e53536.
11. Huque MF,. Experiences with meta-analysis in NDA submissions. Proc. Biopharmaceutical. Section Am. Statist. Assoc. 1988; 2: 28-33.
12. Deeks JJ, Higgins JPT, Altman DG, (editors). Chapter 9: analysing data and undertaking meta-analyses. In:, Higgins JPT, Green S, (eds.) Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Updated March 2011. Available from URL: www.cochrane-handbook.org.
13. Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV, Rowe BH,. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst. Rev. 2012; 12: CD002308.
14. Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality. January 2014. [Accessed 2 Apr 2015]. Available from URL www.effectivehealthcare.ahrq.gov.
15. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097.
16. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati AD, Petticrew M, Shekelle P, Stewart LA,. The Prisma-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 349: g7647.
17. Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gotzsche PC, Lasserson T, Tovey D,. PRISMA for abstracts group. PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med. 2013; 10: e1001419.
18. Wolfe R, Abramson MJ,. Modern statistical methods in respiratory medicine. Respirology 2014; 19: 9-13.
19. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR,. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Syn. Meth. 2010; 1: 97-111.
20. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR,. Introduction to meta-analysis. John Wiley & Sons, Ltd, Hoboken, NJ, 2009.
21. Cooper H, Hedges LV, Valentine JC,. The handbook of research synthesis and meta-analysis, 2nd edn. Russell Sage Foundation, New York, 2009.
22. Hedges LV, Vevea JL,. Fixed- and random-effects models in meta-analysis. Psychol. Methods 1998; 3: 486-504.
23. Bradburn MJ, Deeks JJ, Berlin JA, Russell LA,. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat. Med. 2007; 26: 53-77.
24. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-88.
25. Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, Kuss O, Higgins JP, Langan D, Salanti G,. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res. Synth. Methods 2015; 7: 55-79.
26. Thompson SG, Higgins JP,. How should meta-regression analyses be undertaken and interpreted? Stat. Med. 2002; 21: 1559-73.
27. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR,. Chapter 19: Subgroup analyses. In: Introduction to meta-analysis. John Wiley & Sons, Ltd, Hoboken, NJ, 2009.
28. Borenstein M, Higgins JT,. Meta-analysis and subgroups. Prev. Sci. 2013; 14: 134-43.
29. Thompson SG,. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-5.
30. Higgins JPT, Thompson SG, Spiegelhalter DJ,. A re-evaluation of random-effects meta-analysis. J. R. Stat. Soc. Ser. A. Stat. Soc. 2009; 172: 137-59.
31. Riley RD, Higgins JP, Deeks JJ,. Interpretation of random effects meta-analyses. BMJ 2011; 342: d549.
32. Riley RD, Gates S, Neilson J, Alfirevic Z,. Statistical methods can be improved within Cochrane pregnancy and childbirth reviews. J. Clin. Epidemiol. 2011; 64: 608-18.
33. Poole C, Greenland S,. Random-effects meta-analyses are not always conservative. Am. J. Epidemiol. 1999; 150: 469-75.
34. Egger M, Smith GD,. Bias in location and selection of studies. BMJ 1998; 316: 61-6.
35. Kjaergard LL, Villumsen J, Gluud C,. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann. Intern. Med. 2001; 135: 982-9.
36. Nuesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, Egger M, Juni P,. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010; 341: c3515.
37. Cochran WG,. The Combination of Estimates from Different Experiments. Biometrics 1954; 10: 101-29.
38. Hardy RJ, Thompson SG,. Detecting and describing heterogeneity in meta-analysis. Stat. Med. 1998; 17: 841-56.
39. Davey J, Turner RM, Clarke MJ, Higgins JP,. Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med. Res. Methodol. 2011; 11: 160.
40. Higgins J, Thompson S, Deeks J, Altman D,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
41. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JPT,. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int. J. Epidemiol. 2012; 41: 818-27.
42. Viechtbauer W,. Conducting Meta-Analyses in R with the metafor. J. Stat. Softw. 2010; 36.
43. Laird NM, Mosteller F,. Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care 1990; 6: 5-30.
44. Bonett DG,. Meta-analytic interval estimation for standardized and unstandardized mean differences. Psychol. Methods 2009; 14: 225-38.
45. Demets DL,. Methods for combining randomized clinical trials: strengths and limitations. Stat. Med. 1987; 6: 341-50.
46. Herbison P, Hay-Smith J, Gillespie WJ,. Adjustment of meta-analyses on the basis of quality scores should be abandoned. J. Clin. Epidemiol. 2006; 59: 1249-56.
47. Juni P, Witschi A, Bloch R, Egger M,. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-60.
48. Higgins J, Altman D, Goetzsche P, Juni P, Moher D, Oxman A, SavovicA J, Schulz K, Weeks L, Sterne J,. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
49. Higgins JPT, Altman DG, Sterne JAC, (editors). Chapter 8: assessing risk of bias in included studies. In:, Higgins JPT, Green S, (eds.) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Updated March 2011. Available from URL: www.cochrane-handbook.org
50. Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, et al., Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann. Intern. Med. 2012; 157: 429-38.
51. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA,. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336: 601-5.
52. Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, Hing C, Kwok CS, Pang C, Harvey I,. Dissemination and publication of research findings: an updated review of related biases. Health Technol. Assess. 2010; 14 (iii): ix-xi 1-193.
53. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, et al., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002.
54. Dwan K, Altman DG, Clarke M, Gamble C, Higgins JPT, Sterne JAC, Williamson PR, Kirkham JJ,. Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med. 2014; 11: e1001666.
55. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR,. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst. Rev. 2011; (1): MR000031.
56. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L,. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J. Clin. Epidemiol. 2008; 61: 991-6.
57. Anzures-Cabrera J, Higgins JPT,. Graphical displays for meta-analysis: an overview with suggestions for practice. Res. Syn. Meth. 2010; 1: 66-80.
58. Sedgwick P,. How to read a forest plot in a meta-analysis. BMJ 2015; 351: h4028.
59. Feinstein AR,. Meta-analysis: statistical alchemy for the 21st century. J. Clin. Epidemiol. 1995; 48: 71-9.
60. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L,. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015; 4: 1.
61. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L,. An international registry of systematic-review protocols. Lancet 2011; 377: 108-9.
62. Deeks JJ,. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat. Med. 2002; 21: 1575-600.
63. Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schunemann H,. Framing of health information messages. Cochrane Database Syst. Rev. 2011; (12): CD006777.
64. Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, Brozek J, Norris S, Meerpohl J, Djulbegovic B, et al., GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J. Clin. Epidemiol. 2013; 66: 158-72.
65. Friedrich JO, Adhikari NK, Beyene J,. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med. Res. Methodol. 2008; 8: 32.
66. Jones PW, Quirk FH, Baveystock CM,. The St George's Respiratory Questionnaire. Respir. Med. 1991; 85 (Suppl B): 25-31 discussion 3-7.
67. Gotzsche PC,. Reporting of outcomes in arthritis trials measured on ordinal and interval scales is inadequate in relation to meta-analysis. Ann. Rheum. Dis. 2001; 60: 349-52.
68. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR,. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.